We had FOUR GREAT ANNOUNCEMENTS in the new year (of how many of our/your other holdings can you say the same!):
-Imugene adding industry leaders to Senior Management.
-Imugene completes Phase 1 trial of PD1-Vaxx (with one patient tumor burden reduced to zero!).
-Imugene granted Korean HerVaxx Patent.
-Imugene receives 6.54M R&D tax incentive.
Imugene has been consistent in delivering its shareholders with only good news. Don't trust your frustrated feelings, but look at the facts. For many LT holders, your 15 bags may feel like it's only 10 bags now but maybe that's because your shoulders have become stronger over the years holding onto Imugene .
I think LS is sending out a message here to frustrated shareholders!
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)